Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Adamax vs Cerebrolysin
An educational, source-based comparison of Adamax and Cerebrolysin — how each peptide works, what it's researched for, and what to know before going deeper.
A modified form of Semax with additional N-terminal adamantyl group. Research suggests enhanced stability and penetration across the blood-brain barrier, with amplified neurotrophic and neuroprotective effects compared to parent compound.
- Neuroprotection in acute ischemia
- Cognitive enhancement in healthy adults
- Recovery from traumatic brain injury
- • Russian-origin research; limited Western clinical data.
- • Not FDA-approved.
Porcine-derived peptide mixture researched in neurologic recovery.
A mixture of low-molecular-weight peptides and amino acids derived from purified porcine brain tissue. Research suggests neurotrophic-like activity mimicking BDNF, NGF, and GDNF signaling.
- Ischemic stroke recovery
- Traumatic brain injury
- Vascular dementia and Alzheimer's adjunct
- • Approved in many countries; not FDA-approved in the US.
- • Mixture composition is not fully characterized.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Adamax | Adamax pharmacokinetics and neuroprotection | Molecular Neurobiology | 2019 | Enhanced BBB penetration and neuroprotective efficacy versus Semax in rodent models. |
| Cerebrolysin | Cerebrolysin in acute ischemic stroke (CARS trial) | Stroke | 2016 | Improved early motor recovery in combination with rehabilitation. |
Side-effect & safety grid
- Russian-origin research; limited Western clinical data.
- Not FDA-approved.
- Approved in many countries; not FDA-approved in the US.
- Mixture composition is not fully characterized.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Adamax vs Cerebrolysin — Key differences
- Class: Adamax is classified as Nootropic · Neuroprotection, while Cerebrolysin is Neurotrophic · Mixture.
- Primary research focus: Adamax — neuroprotection in acute ischemia; Cerebrolysin — ischemic stroke recovery.
- Tag: Cognition vs Cognition · Neuroprotection.